uniQure
QURE
#6052
Rank
HK$7.23 B
Marketcap
HK$115.69
Share price
-5.32%
Change (1 day)
13.31%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -HK$1.76 Billion

According to uniQure's latest financial reports the company's current earnings are HK$15.75 Million. In 2024 the company made an earning of -HK$1.86 Billion, an increase over its 2023 earnings that were of -HK$2.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.76 Billion-5.78%
2024 -HK$1.86 Billion-22.65%
2023 -HK$2.41 Billion139.01%
2022 -HK$1.01 Billion-138.54%
2021 HK$2.60 B-335.29%
2020 -HK$1.11 Billion13.88%
2019 -HK$0.98 Billion49.51%
2018 -HK$0.66 Billion4.55%
2017 -HK$0.63 Billion12.65%
2016 -HK$0.56 Billion-9.59%
2015 -HK$0.62 Billion66.95%
2014 -HK$0.37 Billion30.8%
2013 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$70.30 B-4,093.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.30 B-3,525.82%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-HK$0.86 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-HK$1.57 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.77 B-314.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-HK$5.37 Billion 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA